Let's dive into the fascinating world of healthcare investments and explore why companies like Cochlear Ltd (COH) might be worth adding to your watchlist.
The COH Share Price: A Healthcare Leader's Journey
Cochlear, a Sydney-based medical device pioneer, has seen its share price drop by over 50% since the start of 2025. But is this a sign of weakness, or an opportunity for savvy investors?
With a mission to enhance the lives of those with hearing conditions, Cochlear has made significant strides, delivering over 750,000 implantable devices and employing a global workforce of over 5,000.
The Appeal of Healthcare Shares
The ASX Healthcare Index has outperformed the broader market over the last five years, and there are compelling reasons to consider healthcare companies like COH:
Sticky Revenue
Healthcare spending is often essential, making it resilient during economic downturns. Unlike cyclical businesses, healthcare companies enjoy stable revenue streams, as people prioritize their health. This stability was evident during the Global Financial Crisis, when healthcare emerged as the best-performing sector.
Growth Potential
Global healthcare spending is projected to surge, particularly in the US, which accounts for a significant portion of the global total. Sub-sectors like healthcare IT, data solutions, and SaaS are forecast to experience rapid growth, attracting investor interest.
Ethical Investing
The rise of sustainable and ethical investing presents an opportunity for healthcare companies. With investors increasingly allocating funds to sectors providing essential public services, healthcare is well-positioned to attract new capital.
COH Share Price Valuation
As a growth company, Cochlear's price-to-sales multiple provides insights. Currently trading below its historical average, the share price could indicate either a decline or increased sales. In COH's case, revenue has been on an upward trajectory over the last three years.
However, it's crucial to consider context and employ multiple valuation techniques. Rask's free online investing courses offer valuable insights into models like Discounted Cash Flow (DCF) and Dividend Discount Models (DDM), providing a more comprehensive approach to valuation.
Final Thoughts
While the COH share price has experienced a downturn, the underlying strengths of Cochlear as a company and the broader healthcare sector's resilience and growth potential make it an intriguing prospect for investors. As always, thorough research and a nuanced understanding of valuation techniques are essential when making investment decisions.
